Journal profile
Research in Molecular Medicine
ISSN 2322-1348 · eISSN 2322-133X · Mazandaran University of Medical Sciences and Health Services · Iran, Islamic Republic of
Research in Molecular Medicine: diamond open access (no APC); no APC; review about 21 weeks (community reports); 23 articles in 2025.
Scope
Aims, scope and focus
Research in Molecular Medicine is published by Mazandaran University of Medical Sciences and Health Services. By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Sperm and Testicular Function and Essential Oils and Antimicrobial Activity, together about 18.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Research in Molecular Medicine (RMM) is devoted to the rapid publication of fundamental and applied research articles on all aspects of molecular medicine. RMM will bring together work focusing on common pathogenic processes and provide a forum for integrative reviews and commentaries on this field. RMM will cover studies related to clinical and experimental original papers, review articles and correspondence of the highest quality pertinent to all aspects of human biology and pathophysiology. RMM is committed to providing an efficient service for both authors and readers and exists to facilitate the rapid peer review and publication of research. With the support of internal and external Editorial Boards and a streamlined peer-review system, all papers are rapidly and fairly peer-reviewed to ensure they are technically sound.
From the journal's Aims & Scope
Editorial board by country: none in mainland China; most named Iran 32, United States 2, United Kingdom 2, India 1, Australia 1 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology8.8%
- Sperm and Testicular FunctionMedicine4.9%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4.9%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology4.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.4%
- Mesenchymal stem cell researchMedicine4.4%
- Antimicrobial Resistance in StaphylococcusMedicine4.4%
- Reproductive Biology and FertilityMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 12OpenAlex ·
- i10-index
- 19OpenAlex ·
- 2-year mean citedness
- 0.21OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 275 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 63 |
| 2025 | 23 | 23 | 92 |
| 2024 | 6 | 6 | 99 |
| 2023 | 13 | 13 | 98 |
| 2022 | 17 | 17 | 78 |
| 2021 | 30 | 30 | 74 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 21 weeksLetPub ·
- Submission to publication (journal-reported)
- about 21 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 400 words
- Keywords
- ≥ 3
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, Open access, Peer review, Trial registration / reporting guidelines
- Conflicts of interest Conflicts of Interest
All authors of submitting articles to the journal must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The Editor will discuss with the authors on an indiv…
Source ↗Publisher website ·- Publication ethics
RMM follows COPE's Code of Conduct and Declaration of Helsinki for publication and research ethics. Model summary
RMM is committed to apply ethics of publication, based on the COPE’s Code of Conduct and Best Practices. Also, in medical studies, RMM has engaged to apply ethics of research, based on Declaration of Helsinki: Statement of Ethical Principles for Medical Research.
Source ↗Publisher website ·- Open access
No submission, processing, or publication fees are charged for articles in RMM. Model summary
Submission, processing or publication of articles in the RMM is free of charge.
Source ↗Publisher website ·- Peer review
Clinical trial results must be registered in a publicly-accessible registry (e.g., clinicaltrials.gov, IRCT) to be considered for publication. Model summary
we endorse the policy of the International Committee of Medical Journal Editors to refuse to publish papers on clinical trial results if the trial was not recorded in a publicly-accessible registry at its outset.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
Neither the editors nor the publisher are responsible for the opinions expressed by contributors. We reserve the right to copy-edit accepted manuscripts and put them onto our website. Authors should follow the relevant guidelines for the care and use of laboratory animals of their institution or national animal welfare committee. For the sake of transparency in regard to the performance and report…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Mazandaran University of Medical Sciences and Health Services
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2322-1348
- Electronic ISSN
- 2322-133X
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Research in Molecular Medicine
How long does peer review take at Research in Molecular Medicine?
Authors report an average review time of about 21 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Research in Molecular Medicine?
According to the journal's author guidelines: Abstract: ≤ 400 words; Keywords: ≥ 3; Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Research in Molecular Medicine based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (32), United States (2) and United Kingdom (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Research in Molecular Medicine?
According to LetPub and DOAJ records, Research in Molecular Medicine is indexed in DOAJ.
Is Research in Molecular Medicine open access, and what is the APC?
Research in Molecular Medicine is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .